1. Home
  2. RVPH vs SHIM Comparison

RVPH vs SHIM Comparison

Compare RVPH & SHIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVPH
  • SHIM
  • Stock Information
  • Founded
  • RVPH 2006
  • SHIM 1990
  • Country
  • RVPH United States
  • SHIM United States
  • Employees
  • RVPH N/A
  • SHIM N/A
  • Industry
  • RVPH Biotechnology: Pharmaceutical Preparations
  • SHIM
  • Sector
  • RVPH Health Care
  • SHIM
  • Exchange
  • RVPH Nasdaq
  • SHIM Nasdaq
  • Market Cap
  • RVPH 88.0M
  • SHIM 75.7M
  • IPO Year
  • RVPH N/A
  • SHIM 2023
  • Fundamental
  • Price
  • RVPH $1.39
  • SHIM $2.07
  • Analyst Decision
  • RVPH Strong Buy
  • SHIM Hold
  • Analyst Count
  • RVPH 5
  • SHIM 2
  • Target Price
  • RVPH $11.40
  • SHIM $3.00
  • AVG Volume (30 Days)
  • RVPH 1.4M
  • SHIM 8.9K
  • Earning Date
  • RVPH 04-14-2025
  • SHIM 03-27-2025
  • Dividend Yield
  • RVPH N/A
  • SHIM N/A
  • EPS Growth
  • RVPH N/A
  • SHIM N/A
  • EPS
  • RVPH N/A
  • SHIM N/A
  • Revenue
  • RVPH N/A
  • SHIM $514,746,000.00
  • Revenue This Year
  • RVPH N/A
  • SHIM N/A
  • Revenue Next Year
  • RVPH N/A
  • SHIM $3.01
  • P/E Ratio
  • RVPH N/A
  • SHIM N/A
  • Revenue Growth
  • RVPH N/A
  • SHIM N/A
  • 52 Week Low
  • RVPH $0.60
  • SHIM $1.47
  • 52 Week High
  • RVPH $4.33
  • SHIM $7.99
  • Technical
  • Relative Strength Index (RSI)
  • RVPH 31.30
  • SHIM 31.97
  • Support Level
  • RVPH $1.36
  • SHIM $2.00
  • Resistance Level
  • RVPH $1.88
  • SHIM $2.24
  • Average True Range (ATR)
  • RVPH 0.15
  • SHIM 0.11
  • MACD
  • RVPH -0.06
  • SHIM -0.03
  • Stochastic Oscillator
  • RVPH 7.59
  • SHIM 1.64

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.

About SHIM Shimmick Corporation

Shimmick Corp is a leading provider of water and other critical infrastructure solutions nationwide. It selectively focuses on the following types of infrastructure projects: Water Treatment, Water Resources, and Other Critical Infrastructure. In water treatment projects the company expands, rehabilitates, upgrades, builds and rebuilds water and wastewater treatment infrastructure, including desalination plants. In water resources projects company builds, expands, and improves water storage and conveyance, dams, levees, flood control systems, pump stations, and coastal protection. In Other Critical Infrastructure projects, It builds, retrofits, expands, rehabilitates, operates, and maintains its nation's critical infrastructure, including mass transit, bridges, and military infrastructure.

Share on Social Networks: